Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Clene Inc.

Start price
Target price
Perf. (%)
€2.10
04.10.22
-
04.10.23
-71.43%
05.10.23

Probably not worthwhile Investment
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.38
03.10.22
€7.00
03.10.23
-44.51%
06.10.22

Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€1.32
03.10.22
€1.00
03.10.23
6.07%
19.11.22

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€4.14
03.10.22
€4.00
03.10.23
-14.21%
04.10.23

Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€1.74
03.10.22
€2.35
03.10.23
-15.49%
13.02.23

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Hipay Group S.A.

Start price
Target price
Perf. (%)
€4.18
03.10.22
€11.00
03.10.23
7.90%
24.10.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
positive Cash Flow expected
Very low/no dividend yield expected
Heritage Insurance Holdings Inc

Start price
Target price
Perf. (%)
€2.34
03.10.22
-
03.10.23
30.77%
24.04.23

Risky Investment
buy
Energiekontor

Start price
Target price
Perf. (%)
€85.20
03.10.22
-
03.10.23
-11.50%
03.10.23

buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.89
02.10.22
-
02.10.23
-11.24%
16.10.22

Risky Investment
buy
Kaufman & Broad S.A.

Start price
Target price
Perf. (%)
€20.50
01.10.22
-
01.10.23
32.20%
02.10.23

Could be worthwhile Investment >10% per year
buy
Aadi Bioscience Inc.

Start price
Target price
Perf. (%)
€14.18
01.10.22
-
01.10.23
-48.66%
16.03.23

Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.76
30.09.22
-
30.09.23
39.41%
03.10.22

Risky Investment
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€66.50
30.09.22
€120.00
31.12.24
324.36%
05.05.23

Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.70
30.09.22
€9.00
31.01.23
-12.08%
03.01.23

Could be very worthwhile Investment >20% year
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€69.48
29.09.22
€80.00
31.12.24
17.30%
05.05.23

Could be very worthwhile Investment >20% year
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
buy
7C Solarparken

Start price
Target price
Perf. (%)
€4.59
29.09.22
-
29.09.23
-30.17%
30.09.23

buy
Helma Eigenheimbau AG

Start price
Target price
Perf. (%)
€25.20
29.09.22
-
29.09.23
-77.70%
30.09.23

buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€9.04
29.09.22
€11.00
29.03.23
-18.84%
29.03.23

buy
KWS Saat SE & Co. KGaA

Start price
Target price
Perf. (%)
€56.00
29.09.22
€65.00
29.09.23
0.71%
30.05.23

Prothena Corp. plc

Start price
Target price
Perf. (%)
€54.86
28.09.22
-
28.09.23
12.14%
01.10.22

Risky Investment
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.16
27.09.22
-
27.09.23
-4.31%
01.10.22

Risky Investment
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.41
27.09.22
€11.60
27.09.23
8.69%
17.10.22

Could be very worthwhile Investment >20% year